Michael Weiner
FounderFounder at Abbratech Inc.
Branford, Connecticut, United States
FoundedAbbratech Inc.
Find your path to Michael
201 people in our graph share verified history with Michael β schools, employers, funds. One of them is your warm intro.
About
Michael Weiner is the founder and CEO of Abbratech and Precision Biotools, and the founder of Encodia. He previously founded Affomix (acquired by Illumina), AxioMx (acquired by Abcam), and GnuBio (acquired by BioRad), and served as CSO of 454 Life Sciences (acquired by Roche) and RainDance Technologies (acquired by BioRad). He holds a Ph.D. in genetics from Cornell University, is named as an inventor on numerous patents including QuikChange Mutagenesis, has received over $30M in research grant funding, and has been awarded the Connecticut Entrepreneur of the Year and CiteAb Lifetime Achievement awards.
Founder at Abbratech Inc.
Intro paths
In turn, Michael can intro founders to Abbratech Inc.'s investors below.
Abbratech Inc.'s investors Β· 2
Experience
- Abbratech and Precision BiotoolsFounder and CEOcurrent2020 β presentBranford, Connecticut, United States
- EncodiaCo-Foundercurrent2017 β presentGreater San Diego Area
- Next Generation Tile (NextGen Tile)Ownercurrent2010 β presentGuilford, CT
- AbcamV.P. Research2015 β 2021Branford, CT
- AxioMx Inc. (Acquired by Abcam in 2015)Founder and Chief Scientific Officer2012 β 2015Branford, CT
- GnuBIO, Inc (Acquired by BioRad in 2014)Founder and Scientific Consultant2008 β 2014Cambridge, MA
- Affomix Corp (acquired by Illumina, Inc in 2010)Founder and CSO2006 β 2012Branford, CT
- RainDance TechnologiesV.P., Molecular Sciences2003 β 2007
- Rothberg InstituteDirector2002 β 2006
- 454 Life SciencesV.P., Molecular Sciences2000 β 2003
- GlaxoSmithKlineHead, Dept. of Genomic Sciences1995 β 2000
- StratageneSr. Staff Scientist1989 β 1995
Skills & more
+8 more
MicrofluidicsBiomarkersHigh Throughput ScreeningImmunologyMolecular CloningMolecular GeneticsBiomarker DiscoveryInfectious DiseasesFrom Michael's professional profile.
Frequently asked questions
- Who is Michael Weiner?
- Michael Weiner is the founder and CEO of Abbratech and Precision Biotools, and the founder of Encodia. He previously founded Affomix (acquired by Illumina), AxioMx (acquired by Abcam), and GnuBio (acquired by BioRad), and served as CSO of 454 Life Sciences (acquired by Roche) and RainDance Technologies (acquired by BioRad). He holds a Ph.D. in genetics from Cornell University, is named as an inventor on numerous patents including QuikChange Mutagenesis, has received over $30M in research grant funding, and has been awarded the Connecticut Entrepreneur of the Year and CiteAb Lifetime Achievement awards.
- Where does Michael Weiner work?
- Michael Weiner is Founder of Abbratech Inc..
- What companies did Michael Weiner found?
- Michael Weiner founded Abbratech Inc..
- Where did Michael Weiner go to school?
- Michael Weiner studied at Cornell University (Post-doc, Physical Chemistry); Cornell University (Ph.D., Genetics); Penn State University (B. sci., Microbiology and Immunology).
Founder mafias
Cornell mafia535
Also came through, then founded or led a company.
+ 528 more
Penn State University mafia152
Also came through, then founded or led a company.
+ 145 more
Raindance Technologies mafia3
Also came through, then founded or led a company.
Same school
Also attended Cornell University1,266
+ 1,260 more
Also attended Penn State University412
+ 406 more
Shared employers
Also worked at Encodia1
Also worked at Abcam5
Also worked at RainDance Technologies6
Also worked at GlaxoSmithKline204
+ 198 more











































